|
New Tool For Understanding Estrogen-Fueled Breast Cancer Provided By Molecular Atlas (Medical News Today)
Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed. [click link for full article]
(Oct 5, 2006)
BioDiscovery Releases a New Array CGH Analysis Module for ImaGene 7.0 (PR Web)
BioDiscovery Inc., the leading developer of integrated software solutions for microarray research announced today the release of a completely new aCGH module providing an advanced array-based DNA copy number analysis and visualization tool. (PRWeb Oct 5, 2006) Trackback URI: http://www.prweb.com/zingpr.php/WmV0YS1JbnNlLVNpbmctRmFsdS1JbnNlLVplcm8=
(Oct 5, 2006)
Genetic Map Adds to Cancer Research (The Harvard Crimson)
A recent study headed by researchers at the Harvard-affiliated Dana-Farber Cancer Institute has identified a complete map of the genetic regions that may influence how estrogen contributes to breast cancer—results that could advance clinical treatment for breast cancer patients.
(Oct 5, 2006)
Santa Cruz makes move to check growth at UC (San Jose Mercury News)
The feisty politicians who run Santa Cruz are digging in to fight an ambitious plan that would expand UC-Santa Cruz's size, scope and reputation. Post a Comment
(Oct 5, 2006)
Genomics: Blueprints for partnerships (Nature)
Gutless marine worms harness the resources of a team of bacteria in lieu of a digestive or excretory system. A genome-sequence analysis now defines the roles of the microbes.
(Oct 5, 2006)
Co-evolution of transcriptional and post-translational cell-cycle regulation (Nature)
DNA microarray studies have shown that hundreds of genes are transcribed periodically during the mitotic cell cycle of humans, budding yeast, fission yeast and the plant Arabidopsis thaliana. Here we show that despite the fact the protein complexes involved in this process are largely the same among all eukaryotes, their regulation has evolved considerably. Our comparative analysis of several
(Oct 5, 2006)
DNAPrint Genomics Congratulates Biofrontera AG on Successful Clinical Trial Stages for Two Drugs (Market Wire via Yahoo! Finance)
DNAPrint Genomics, Inc. today announced that two products being developed by Biofrontera AG, a company in Germany in which DNAPrint Genomics owns an 18.3% stake, have been approved for the next stages of their respective clinical trial processes. The products are Biofrontera's BF-200 ALA treatment for actinic keratosis (precancerous and cancerous skin lesions), its lead product, and BF-derm1, a
(Oct 5, 2006)
IBT Reference Laboratory Appoints Dr. Michelle Hunter Vice President of Sales, Marketing and Corporate Development (PR Newswire via Yahoo! Finance)
IBT Reference Laboratory, an international allergy and immunology laboratory that specializes in contract research for pharmaceutical development, recently named Michelle Hunter, Ph.D., M.B.A. as vice president of sales, marketing and corporate development.
(Oct 5, 2006)
Scientists Pick Apart Fungus for Genetic Clues (Agricultural Research Magazine)
Using the tools of molecular genetics, Agricultural Research Service ( ARS ) scientists are deconstructing the toxin-making machinery of the fungus Fusarium verticillioides to find clues to its contamination of corn.
(Oct 5, 2006)
BioDiscovery Releases a New Array CGH Analysis Module for ImaGene 7.0 (PR Web via Yahoo! News)
El Segundo, CA (PRWEB) October 5, 2006 -- BioDiscovery Inc.
(Oct 5, 2006)
Strategic Diagnostics Inc. Announces NPIP Technical Approval and First Commercial Orders for RapidChek(R) SELECT(TM) (Business Wire via Yahoo! Finance)
NEWARK, Del.----Strategic Diagnostics Inc. , today announced that their new RapidChek® SELECT Salmonella testing product has been approved by the Technical Committee of the National Poultry Improvement Plan as an analytical method for the detection of Salmonella species in NPIP samples.
(Oct 5, 2006)
Looking ahead (USA Today)
The Wednesday whirl: • The Nobel Prize in chemistry will be announced. • Eyes on the the other prize: The X PRIZE Foundation, which sponsors the largest medical prize in history, announces a second award for breakthroughs in genomics. • Economic numbers:...
(Oct 5, 2006)
Sequencing Of The Oyster Mushroom Genome (Science Daily)
Professor of Microbiology at the Public University of Navarre, Antonio Gerardo Pisabarro de Lucas, is leading an international project to sequence the genome of the oyster mushroom. The oyster mushroom, Pleurotus ostreatus, will be the first edible mushroom in the world to be genetically sequenced.
(Oct 5, 2006)
Simple, Sensitive New Way To Detect Activity Of Destructive Enzymes (Science Daily)
Scientists in the United States are reporting discovery of a much-needed new method to identify the activity of destructive enzymes that have been linked to a range of diseases.
(Oct 5, 2006)
Cutting-edge Methods For Analyzing Complex Molecular Interactions (Science Daily)
With the genomes of hundreds of organisms now catalogued, one of the next major challenges is to identify proteins and their interactions. The current issue of CSH Protocols, published online, features two freely available, cutting-edge methods that address this challenge.
(Oct 5, 2006)
Helping Build Designs That Are 'Cool' (Science Daily)
Cool design creates hot profits, and although really great design is an art rather than a craft, the E-VaN project has developed some best-practice design tools to help companies maximise their potential. E-VaN aims to usher in a new wave of design that allies form with function.
(Oct 5, 2006)
Douglas Lane, President, CEO and Chairman of Genesis Bioventures Featured in Exclusive Interview With WallSt.net (PrimeZone via Yahoo! Finance)
Genesis Bioventures, Inc. , announced that Douglas Lane, GBIW's President, CEO, and Chairman, was featured in an exclusive interview with WallSt.net. WallSt.net is a professional forum for the financial community, primarily known for interviews with CEOs and prominent business executives.
(Oct 5, 2006)
New Biomarker Predicts Survival in Colorectal Cancer (Yale University)
New Haven, Conn. — The location and amount of a protein within two separate compartments of a tumor cell may be critical markers predicting survival in colorectal cancer, according to a study at Yale School of Medicine.
(Oct 5, 2006)
DNAPrint Genomics Congratulates Biofrontera AG on Successful Clinical Trial Stages for Two Drugs (SYS-CON Media)
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that two products being developed by Biofrontera AG, a company inGermany in which DNAPrint Genomics owns an 18.3% stake, have been approvedfor the next stages of their respective clinical trial processes. Theproducts are Biofrontera's BF-200 ALA treatment for actinic keratosis(precancerous and cancerous skin lesions), its lead product, and
(Oct 5, 2006)
Scientists pick apart Fusarium verticillioides to find clues to its contamination of corn (SeedQuest)
Using the tools of molecular genetics, Agricultural Research Service (ARS) scientists are deconstructing the toxin-making machinery of the fungus Fusarium verticillioides to find clues to its contamination of corn.
(Oct 5, 2006)
$10 million prize for mapping human genomes (CNN.com)
Read full story for latest details.
(Oct 5, 2006)
Nanogen Announces Consolidation and Cost Reduction Actions (PR Newswire via Yahoo! Finance)
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it plans to reduce staff in North America by approximately 15% by the end of 2006.
(Oct 5, 2006)
Nanogen Announces Consolidation and Cost Reduction Actions (SYS-CON Media)
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it plans to reduce staff in North America by approximately 15% by the end of 2006. The reduction will be achieved through both attrition and consolidation of activities in R&D, manufacturing, sales and marketing.
(Oct 5, 2006)
$10 Million Prize Set Up for Speedy DNA Decoding (New York Times)
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days.
(Oct 6, 2006)
InnovationsKapital Secures SEK 1 Billion for New Investments (Business Wire via Yahoo! Finance)
STOCKHOLM, Sweden----InnovationsKapital, a well established independent early stage venture capital firm, is pleased to announce the closing of the fourth InnKap fund - InnKap 4 Partners.
(Oct 6, 2006)
Affymetrix and NimbleGen Systems Enter into Licensing Agreement (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif. & MADISON, Wis.----Affymetrix Inc. and NimbleGen Systems Inc. announced today that NimbleGen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents covering the manufacture, use and sales of nucleic acid microarrays and related products and services in the research field.
(Oct 6, 2006)
Phosphopeptide Enrichment Kit comes with necessary controls. (ThomasNet)
Using technology based on Ga+3 chelate on silica, PhosphoProfile(TM) I offers proteomics researchers advantages such as low non-specific binding, no bias in selectivity of phosphorylation state, maximum sensitivity, and accelerated sample handling. Phosphoproteins are digested with included Proteomics Grade Trypsin, resulting in phosphopeptides captured in spin-tubes. Up to 25 nanomoles of
(Oct 6, 2006)
Oregon's Center for Coastal Margins to Use Genomics and Proteomics Tools in Research (GenomeWeb News)
If you have already registered, then login here . (To avoid this screen in the future, do not logout.)
(Oct 6, 2006)
Researchers to develop active nanoscale surfaces for biological separations (EurekAlert!)
A team of researchers has received a four-year, $1 million grant from the National Science Foundation to study improved methods for biological separations. Led by Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, the group plans to develop nanoscale surfaces that actively reassemble in the presence of DNA, which could eventually
(Oct 6, 2006)
NimbleGen licenses Affymetrix patents (bizjournals.com via Yahoo! Finance)
NimbleGen Systems Inc. has obtained a non-exclusive, worldwide license to a number of patents from a California firm in a move the Madison biotech firm hopes will accelerate sales.
(Oct 6, 2006)
Mayo Clinic gets $72 mil grant for developing drug treatments (The Arizona Republic)
The National Institutes of Health award The Mayo Clinic a $72 million research grant to speed development and delivery of drugs to patients. The Arizona portion of the money will support Mayo's collaborations with Arizona State University and the Translational Genomics Research Institute.
(Oct 6, 2006)
Affymetrix in licensing deal with Wisconsin company (bizjournals.com via Yahoo! Finance)
Affymetrix Inc. and NimbleGen Systems Inc. said Friday they entered a licensing agreement over some Affymetrix patents covering manufacture, use and sales of nucleic acid microarrys.
(Oct 6, 2006)
October MCP: A special issue on Clinical Proteomics (EurekAlert!)
The October 2006 issue of the journal Molecular and Cellular Proteomics (MCP) will focus specifically on biomarker discovery and clinical proteomics. This is the fourth special clinical issue produced by the Journal, and it is available free to the public on the MCP website ( www.mcponline.org ).
(Oct 6, 2006)
Danaos Shares Slip in Debut (AP via Yahoo! Finance)
Shares of Danaos Corp. fell slightly Friday, as the Greek shipping company had its trading debut on the New York Stock Exchange.
(Oct 6, 2006)
Danaos Shares Slip in Debut (KiplingerForecasts.com)
Shares of Danaos Corp. fell slightly Friday, as the Greek shipping company had its trading debut on the New York Stock Exchange. In early afternoon trading, the shares were down 15 cents from the IPO price of $21.
(Oct 6, 2006)
What Is Proteomics? (BioresearchOnline)
Proteomics is the large-scale study of protein, particularly their structures and functions. This term was coined to make an analogy with genomics, and while it is often viewed as the "next step", proteomics is much more complicated than genomics
(Oct 6, 2006)
I’m a Celebrity, Get My Sequence! (Bio-IT World)
October 06, 2006 | COMMENTARY | Two years ago, the X Prize Foundation awarded $10 million for the first sub-orbital spaceflight. Now, a new prize -- the Archon X Prize for Genomics -- has been formally established.
(Oct 6, 2006)
UAlbany researcher gets $2.2M in federal funds for cancer research (Albany Business Journal)
A scientist at the University at Albany's Gen*NY*Sis Center for Excellence in Cancer Genomics has won a $2.2 million award from the National Institute of Environmental Health Services.
(Oct 6, 2006)
Lifeline Therapeutics, Inc. Elects Dr. Larry Gold to Board of Directors; Dr. Gold Brings Decades of Business Leadership (RedNova)
Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, a patent-pending dietary supplement that increases the body's natural antioxidant defenses, today announced the appointment of Larry Gold, Ph.D. to its Board of Directors. Dr.
(Oct 6, 2006)
SPECTRUM EDITOR TALKS ABOUT FELLOWS (Spectrum Online)
Listen to Susan Hassler, editor-in-chief of IEEE Spectrum , talk about the magazine and about the results of the latest IEEE Fellows Survey ȁ4;concerning tech trends over the next 50 yearsȁ4;today on Science and Society's weekly podcast . Hasslerȁ4;along with Gary Fedder (the Howard M. Wilkoff Professor of Electrical and Computer Engineering and the Director of the Institute for Complex
(Oct 6, 2006)
$10 Million Prize Set Up for Speedy DNA Decoding (New York Times)
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days.
(Oct 7, 2006)
Pioneers on genetic frontier (The Arizona Republic)
For scientist Johanna Wolford, inspiration may strike when she is swimming or knitting. As she's lapping waves or clacking knitting needles, she lets her mind wander, and it just happens.
(Oct 7, 2006)
New Biomarker Predicts Survival In Colorectal Cancer (Medical News Today)
The location and amount of a protein within two separate compartments of a tumor cell may be critical markers predicting survival in colorectal cancer, according to a study at Yale School of Medicine. [click link for full article]
(Oct 7, 2006)
Researchers To Develop Active Nanoscale Surfaces for Biological Separations (Newswise)
A team of researchers has received a four-year, $1 million grant from the NSF to study improved methods for biological separations. Led by Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer, the group plans to develop nanoscale surfaces that actively reassemble in the presence of DNA, which could eventually lead to more efficient separation tools for
(Oct 7, 2006)
Yale School Of Medicine Awarded $57 Million For Bench-to-Bedside Research (Medical News Today)
As part of a major national initiative to speed research from the laboratory bench to patients in need, Yale School of Medicine Tuesday received a $57.3 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH).The funding includes $31.5 million in new resources that will greatly strengthen clinical research at Yale and $25. [click link for full article]
(Oct 7, 2006)
Institutions creating a mecca of Alzheimer's research (The Arizona Republic)
The Arizona Alzheimer's Consortium has created a national powerhouse by combining a stellar brain bank, well-known PET scan and MRI programs.
(Oct 8, 2006)
Pine Crest siblings qualify to take courses at Duke (Boca Raton News)
Boca siblings Blair and James Baker may go to Duke sooner than most.
(Oct 8, 2006)
Trustee says his tenure stands strong (North County Times)
Editor's note: Ninth in a series focusing on 12 candidates seeking three seats on the Temecula Valley Unified School District board. The election is Nov. 7.
(Oct 8, 2006)
$10 Million Prize Set Up for Speedy DNA Decoding (New York Times)
The terms of the prize, announced by the X Prize Foundation of Santa Monica, Calif., require competitors to sequence 100 human genomes of their choice within 10 days.
(Oct 8, 2006)
Institutions creating a mecca of Alzheimer's research (The Arizona Republic)
The Arizona Alzheimer's Consortium has created a national powerhouse by combining a stellar brain bank, well-known PET scan and MRI programs.
(Oct 8, 2006)
|
